IDEXX Laboratories, Inc.
IDXX
Kedudukan dalam Saham
#559
IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing,... IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.
Harga Saham
$556.46
Disegerakkan terakhir: 2026-10-20
Modal Pasaran
$43.84B
Perubahan (1 hari)
0.12%
Perubahan (1 tahun)
-12.66%
Negara
US
Perdagangan IDEXX Laboratories, Inc. (IDXX)
Kategori
Healthcare
Nisbah P/E bagi IDEXX Laboratories, Inc. (IDXX)
Nisbah P/E pada October 2026 TTM: 37.15
Menurut laporan kewangan dan harga saham terkini IDEXX Laboratories, Inc., nisbah P/E semasa (TTM) ialah 37.15. Pada akhir 2024, syarikat mempunyai nisbah P/E sebanyak 38.40.
Sejarah nisbah P/E bagi IDEXX Laboratories, Inc. dari 2000 hingga 2026
Nisbah P/E pada akhir setiap tahun
| Tahun | Nisbah P/E | Ubah |
|---|---|---|
| 2026 (TTM) | 37.15 | -27.37% |
| 2025 | 51.15 | 33.19% |
| 2024 | 38.40 | -29.62% |
| 2023 | 54.56 | 8.61% |
| 2022 | 50.24 | -33.30% |
| 2021 | 75.32 | 2.72% |
| 2020 | 73.33 | 39.47% |
| 2019 | 52.57 | 22.67% |
| 2018 | 42.86 | -17.83% |
| 2017 | 52.16 | 10.06% |
| 2016 | 47.39 | 34.81% |
| 2015 | 35.15 | -13.82% |
| 2014 | 40.79 | 35.48% |
| 2013 | 30.11 | 5.19% |
| 2012 | 28.62 | 5.96% |
| 2011 | 27.01 | -4.46% |
| 2010 | 28.28 | 9.95% |
| 2009 | 25.72 | 38.12% |
| 2008 | 18.62 | -51.50% |
| 2007 | 38.39 | 44.28% |
| 2006 | 26.61 | -11.05% |
| 2005 | 29.91 | 25.46% |
| 2004 | 23.84 | -14.17% |
| 2003 | 27.78 | 14.17% |
| 2002 | 24.33 | -3.56% |
| 2001 | 25.23 | 21.51% |
| 2000 | 20.76 | 0.00% |
Nisbah P/E untuk syarikat serupa atau pesaing
| Syarikat | Nisbah P/E | Perbezaan Nisbah P/E | Negara |
|---|---|---|---|
| 36.15 | -2.68% |
US
|
|
| 39.77 | 7.06% |
US
|
|
| -290.26 | -881.32% |
US
|
|
| - | - |
CN
|
|
| 34.18 | -7.98% |
US
|
Cara membaca nisbah P/E
Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.
Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.
Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.